Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development
Category: Press Releases
International consortium to revolutionize viral vector manufacturing
Collaborative Project to Develop Next-Generation Cell Platform for Viral Vector Production Receives £1.1 Million Grant from Innovate UK & NRC.